Journal
type: Class

Information Content Entity
type: Class

Continuant
type: Class

Entity
type: Class

Periodical
type: Class

Generically Dependent Continuant
type: Class

Collection
type: Class

RDF description of ANNALS OF ONCOLOGY - http://research.umh.es/vivo/pub/revista/0923-7534
type: Document
rights: termsOfUse
date: 2026-08-29T20:17:05
publisher: ANNALS OF ONCOLOGY

ANNALS OF ONCOLOGY
type: Information Content Entity
type: Continuant
publication venue for: Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer
type: Journal
most specific type: Journal
publication venue for: Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer (SCLC): A Spanish Lung Cancer Group phase II study
type: Periodical
type: Thing
type: Collection
type: Entity
publication venue for: FAC (fluorouracil, doxorubicin, cyclophosphamide) versus CMF (cyclophosphamide, methotrexate, fluorouracil) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group.
publication venue for: Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial
issn: 0923-7534
publication venue for: Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
publication venue for: Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial.
publication venue for: Phase I/II trial of Irinotecan plus weekly 48-h continuous infusion of high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy of advanced colorectal cancer
type: Generically Dependent Continuant
publication venue for: Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: Long-term results of the Spanish GCR-3 phase II randomized trial

Phase II trial of the novel taxane BMS-184476 as second-line in non-small-cell lung cancer
type: Year2005
type: Continuant
type: Entity
type: Generically Dependent Continuant
type: Thing
type: AcademicArticle
type: Article
has publication venue: ANNALS OF ONCOLOGY
type: Document
type: Annuality
type: Information Content Entity

Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer (SCLC): A Spanish Lung Cancer Group phase II study
type: Generically Dependent Continuant
type: Annuality
type: Information Content Entity
type: Thing
type: Entity
type: Article
type: Document
type: AcademicArticle
has publication venue: ANNALS OF ONCOLOGY
type: Continuant
type: Year2003

FAC (fluorouracil, doxorubicin, cyclophosphamide) versus CMF (cyclophosphamide, methotrexate, fluorouracil) as adjuvant chemotherapy for operable breast cancer: A study by the GEICAM group.
type: Thing
type: Document
type: Information Content Entity
type: AcademicArticle
has publication venue: ANNALS OF ONCOLOGY
type: Continuant
type: Article
type: Entity
type: Generically Dependent Continuant
type: Annuality
type: Year2003

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial
type: Annuality
has publication venue: ANNALS OF ONCOLOGY
type: AcademicArticle
type: Generically Dependent Continuant
type: Year2006
type: Document
type: Entity
type: Thing
type: Information Content Entity
type: Article
type: Continuant

Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study
type: Thing
type: Year2015
type: Annuality
has publication venue: ANNALS OF ONCOLOGY
type: Generically Dependent Continuant
type: Entity
type: Information Content Entity
type: AcademicArticle
type: Continuant
type: Article
type: Document

Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small cell lung cancer: a spanish lung cancer group trial.
type: Document
type: Article
type: Thing
has publication venue: ANNALS OF ONCOLOGY
type: Generically Dependent Continuant
type: AcademicArticle
type: Annuality
type: Continuant
type: Entity
type: Year2005
type: Information Content Entity

Phase I/II trial of Irinotecan plus weekly 48-h continuous infusion of high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy of advanced colorectal cancer
type: Annuality
type: Continuant
type: Entity
has publication venue: ANNALS OF ONCOLOGY
type: Article
type: Year2004
type: Information Content Entity
type: AcademicArticle
type: Thing
type: Generically Dependent Continuant
type: Document

Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: Long-term results of the Spanish GCR-3 phase II randomized trial
type: Document
type: Generically Dependent Continuant
has publication venue: ANNALS OF ONCOLOGY
type: Information Content Entity
type: Article
type: Annuality
type: Thing
type: Year2015
type: Continuant
type: AcademicArticle
type: Entity